“Propóleos: ¿Restaurador de la función celular en el hígado graso no alcohólico?”
Main Article Content
Abstract
-
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Those authors who have publications with this journal accept the following terms of the License Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
The journal is not responsible for the opinions and concepts expressed in the works, they are the sole responsibility of the authors. The Editor, with the assistance of the Editorial Committee, reserves the right to suggest or request advisable or necessary modifications. They are accepted to publish original scientific papers, research results of interest that have not been published or sent to another journal for the same purpose.
The mention of trademarks of equipment, instruments or specific materials is for identification purposes, and there is no promotional commitment in relation to them, neither by the authors nor by the publisher.
How to Cite
References
Miyal K. Hepatotoxicology, Chapter 13 Structural and Organization of the liver, RG Meek, SD Harrison and RJ. Boca Ratón, Florida, USA 1991; 1-65
Marzella L and Trump BF. Hepatotoxicology, Chapter 3 Patology of the liver. Funtional and Structural Alteration of Hepatocyte Organelles Induced by Cell Injury. RG Meek, SD Harrison and RJ Bull 1991; 93-138.
Angulo P, Lindor K. ”Treatmen of Nonalcoholic fatty liver: Present and emerging therapies sem disease 2000; 21 (1): 81-88.
Malteoni CA, Younossi ZM, Gramlich TI, et al. Nonalcoholic fatti liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413- 1419.
Brunt EM, Janney CG, Dibisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and the histological lesions. Am J Gastroenterol 1999; 94: 2467- 2474.
Ludwig J, Viggiano TR, McGill DB, Ott BJ. Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proc 1980; 55: 434- 438.
Sheth SG, Gordon FD, Chopra S. Non-alcoholic steatohepatitis. Ann Intern Med 1997; 126: 137-145.
Ludwig J, McGill DB, Lindor KD. Review: nonalcoholic steatohepatitis. J Gastroenterology Hepatol 1997; 12: 398-403.
Lee RG. Nonalcoholic steatohepatitis. A study of 49 patients. Hum Pathol 1989; 20: 594-598.
Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990; 12: 1106-1110.
Lavine JE. Vitamin E treatament of nanalcoholic steatohepatitis in children : a pilot study. J Pediatr 2000; 136: 734-738.
Poucell S, Ireton J, Valencia-Mayoral P, Downar E, Larratt L, Patterson J. Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical and electron microscopic studies. Gastroenterology 1984; 86: 926-936.
Götz W. Diagnosisof Hepatic diseases. 1980; 12-15.
Fromety B, Berson A, Pessayre D. Microvesiicular steatosis and steatohepatitis : role of mitocondrial dysfuncion and lipid peroxidation. J Hepatol 1997; 26(suppl): 13-22.
Berson A, De Beco V, Letteron P, Robin M, Moreau C, El Kahwaji J, et al. Steatohepatitis-inducing drug cause mitocondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 1998; 114: 764-74.
Brent A. Ftty liver and nonalcoholic steatohepatitis. Clin Cornstone 2001; 3(6): 47-
Laurin J, Lindor K, Crippin JS, et al. Ursodeoxycholic acid or clorfibrate in treatment of Nonalcoholic–induced steatohepatitis: a pilot study. Hepatology 1996; 23: 1464- 1467.
Basaranogla M, Achay O, Sonsus A. A controlled trial of Gembibrozil in the treatment of Nonalcoholic induced steatohepatitis: A pilot study. Hepatology 1996; 23: 1464-67.
Haseagawa T, Yoneda M, Nakamura K, Yokihama S, Tamonk K, Sato Y. Diagnostic significance of measuring TG levels and effect tocopherol in patients with NASH. Gastroenterology 1997; 112: 1278.
Rodríguez S, Ancheta O, Remires D, et al. El efecto del Propóleo rojo cubano ante el da ño inducido en hepatocitos de roedores. Rev CENIC Ciencias biológicas 1998; Vol 29( 2).
Asís Moisés. Propóleo: El oro púrpura de las abejas. Centro de Inf y doc Agropecuario 1991.
García-Vaguera C, Greenaway W, Whatley F.Composition of propolis from two diferents Spanish Regions. Naturforach 1992; 47c, 634.
Pascual C, González R, Torricella R. Scavenging action of propolis extract against oxigen radicals. J. Ethnolpharmacol 1999 ; 41: 9-13.
Giral R T. Comunicación personal.
González A, Merino N, González R. Valoración del efecto hepatoprotector de un extracto de Propóleo rojo cubano en el modelo de hepatotoxicidad por Galactosamina en ratas. Rev CENIC ciencias biológicas 1994; 25, 36.
Pietrangelo A. Metals,oxidative stress and hepatic fibrogenesis. Semin Liver Dis 1998; 16: 13-30.